Advances in hormone replacement therapy: Weight benefits of drospirenone, a 17α-spirolactone-derived progestogen

Author： Foidart Jean-Michel Faustmann Thomas

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.23, Iss.12, 2007-12, pp. : 692-699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy and safety of 17-hydroxyprogesterone caproate in hormone replacement therapy

By Agostini Riccardo Casini Maria Costabile Loredana Paragona Mizar Marzano Francesca Unfer Vittorio

Gynecological Endocrinology, Vol. 21, Iss. 5, 2005-11 ,pp. : 265-267

Informa Healthcare

Access to resources Recommend Favorite

Hormone Replacement Therapy and Hypertension

By FELMEDEN DIRK C. LIP GREGORY Y. H.

Blood Pressure, Vol. 9, Iss. 5, 2000-12 ,pp. : 246-249

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and cancer

Gynecological Endocrinology, Vol. 15, Iss. 6, 2001-12 ,pp. : 453-465

Informa Healthcare

Access to resources Recommend Favorite

Hormone Replacement Therapy and Stroke

Current Vascular Pharmacology, Vol. 6, Iss. 2, 2008-04 ,pp. : 112-123

Bentham Science Publishers

Access to resources Recommend Favorite

Hormone therapy: Maximizing the benefits

By Heikkinen Jorma

Gynecological Endocrinology, Vol. 22, Iss. 3, 2006-03 ,pp. : 160-162

Informa Healthcare

Access to resources Recommend Favorite